1. Home
  2. LSTA vs GYRO Comparison

LSTA vs GYRO Comparison

Compare LSTA & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GYRO
  • Stock Information
  • Founded
  • LSTA 1980
  • GYRO 1946
  • Country
  • LSTA United States
  • GYRO United States
  • Employees
  • LSTA N/A
  • GYRO N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GYRO Building operators
  • Sector
  • LSTA Health Care
  • GYRO Real Estate
  • Exchange
  • LSTA Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • LSTA 20.0M
  • GYRO 19.3M
  • IPO Year
  • LSTA N/A
  • GYRO N/A
  • Fundamental
  • Price
  • LSTA $2.07
  • GYRO $8.10
  • Analyst Decision
  • LSTA Strong Buy
  • GYRO
  • Analyst Count
  • LSTA 1
  • GYRO 0
  • Target Price
  • LSTA $15.00
  • GYRO N/A
  • AVG Volume (30 Days)
  • LSTA 9.1K
  • GYRO 818.0
  • Earning Date
  • LSTA 05-08-2025
  • GYRO 01-01-0001
  • Dividend Yield
  • LSTA N/A
  • GYRO N/A
  • EPS Growth
  • LSTA N/A
  • GYRO N/A
  • EPS
  • LSTA N/A
  • GYRO N/A
  • Revenue
  • LSTA $1,000,000.00
  • GYRO $2,738,019.00
  • Revenue This Year
  • LSTA N/A
  • GYRO N/A
  • Revenue Next Year
  • LSTA N/A
  • GYRO N/A
  • P/E Ratio
  • LSTA N/A
  • GYRO N/A
  • Revenue Growth
  • LSTA N/A
  • GYRO N/A
  • 52 Week Low
  • LSTA $2.05
  • GYRO $7.65
  • 52 Week High
  • LSTA $4.20
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 34.86
  • GYRO 24.74
  • Support Level
  • LSTA $2.31
  • GYRO $8.13
  • Resistance Level
  • LSTA $2.46
  • GYRO $8.55
  • Average True Range (ATR)
  • LSTA 0.15
  • GYRO 0.11
  • MACD
  • LSTA -0.01
  • GYRO -0.00
  • Stochastic Oscillator
  • LSTA 0.00
  • GYRO 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: